Release Date: 16/09/11 14:06 Summary: Amended Release - ASX Listing Rule 3.4.1 Price Sensitive: No Download Document 98.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%